DENTSPLY SIRONA

XRAY · NASDAQ

$8.87+$0.45 (+5.34%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $8.42

XRAY analyst rating

HoldConsensus of 13 analysts over the last 12 months. 15% rate it a buy.

Strong buy0
Buy2
Hold9
Underperform1
Sell1

12-month price target · 17 analysts

Average $13.82 (+55.8% upside)

Low: $10.10
Now: $8.87
High: $17.85

Upgrades and downgrades

The latest rating actions, newest first

XRAY analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Leerink Partners	Oct 14, 2026	Maintains	Market Perform	$14.00 → $10.00	61%
Piper Sandler	Oct 9, 2026	Maintains	Neutral	$14.00 → $12.00	43%
BMO Capital	Sep 17, 2026	Maintains	Market Perform	$13.00 → $10.00	45%
Barclays	Aug 24, 2026	Maintains	Underweight	$9.00 → $11.00	53%
Piper Sandler	Jul 29, 2026	Maintains	Neutral	$13.00 → $14.00	43%
BMO Capital	Jul 9, 2026	Initiates	Market Perform	$12.00	—
Barclays	Jun 4, 2026	Maintains	Underweight	$12.00 → $9.00	53%
UBS	May 7, 2026	Maintains	Buy	$18.00 → $17.00	70%
Mizuho	May 6, 2026	Maintains	Neutral	$16.00 → $14.00	54%
Citigroup	Apr 15, 2026	Initiates	Sell	$10.00	44%

The case for and against

Updated Apr 28, 2026

Bull case

Dentsply Sirona is showing signs of improvement and progress in its fourth quarter results, with strong top-line and adjusted EPS. The company's performance in the U.S. region has shown positive trends in key areas, and the recent restructuring plan and leadership changes demonstrate a commitment to future growth and success. Furthermore, the decision to eliminate the dividend in order to reduce debt and repurchase shares appears to be a smart move. With a strong financial outlook for 2026 and potential for continued operational progress, the company has a positive outlook for future growth.

Bear case

Dentsply Sirona is struggling operationally and has recently experienced significant executive turnover, including the departure of their CFO. While there is potential for the dental market to stabilize and for the company's various initiatives to improve performance, there is no evidence of this yet and their profitability outlook for FY/26 has been reduced. Additionally, their recent history of management changes and failed turnaround plans adds risk to the investment. Despite trading at bargain basement levels, investing in Dentsply Sirona requires patience and a longer-term mindset. If the new leadership can successfully turn the company around, there is potential for significant upside to the stock price.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.